Terms: = Breast cancer AND U2AF1, ENSG00000160201, 7307, Q01081, U2AFBP, U2AF35, RNU2AF1, RN, FP793, DKFZp313J1712 AND Treatment
28 results:
1. Simultaneous evaluation of brain metastasis and thoracic cancer using semiconductor
Kaneko K; Nagao M; Ueda K; Yamamoto A; Sakai S
Ann Nucl Med; 2024 Apr; 38(4):278-287. PubMed ID: 38386272
[TBL] [Abstract] [Full Text] [Related]
2. Pan-tumor survey of ROS1 fusions detected by next-generation RNA and whole transcriptome sequencing.
Nagasaka M; Zhang SS; Baca Y; Xiu J; Nieva J; Vanderwalde A; Swensen JJ; Spetzler D; Korn WM; Raez LE; Liu SV; Ou SI
BMC Cancer; 2023 Oct; 23(1):1000. PubMed ID: 37853341
[TBL] [Abstract] [Full Text] [Related]
3. Stereoselective synthesis of oxime containing Pd(II) compounds: highly effective, selective and stereo-regulated cytotoxicity against carcinogenic PC-3 cells.
de la Cueva-Alique I; de la Torre-Rubio E; Muñoz-Moreno L; Calvo-Jareño A; Pérez-Redondo A; Gude L; Cuenca T; Royo E
Dalton Trans; 2022 Aug; 51(34):12812-12828. PubMed ID: 35796301
[TBL] [Abstract] [Full Text] [Related]
4. Trastuzumab emtansine increases the risk of stereotactic radiosurgery-induced radionecrosis in HER2 + breast cancer.
Id Said B; Chen H; Jerzak KJ; Warner E; Myrehaug S; Tseng CL; Detsky J; Husain Z; Sahgal A; Soliman H
J Neurooncol; 2022 Aug; 159(1):177-183. PubMed ID: 35715667
[TBL] [Abstract] [Full Text] [Related]
5. Risk of recurrence among patients with HR-positive, HER2-negative, early breast cancer receiving adjuvant endocrine therapy: A systematic review and meta-analysis.
Salvo EM; Ramirez AO; Cueto J; Law EH; Situ A; Cameron C; Samjoo IA
Breast; 2021 Jun; 57():5-17. PubMed ID: 33677313
[TBL] [Abstract] [Full Text] [Related]
6. [Clinical analysis of 12 cases of acute myeloid leukemia complicated with synchronous primary solid tumor].
Mi RH; Dang HB; Chen L; Han YL; Wang MF; Zhang YL; Chen L; Li DB; Wei XD
Zhonghua Yi Xue Za Zhi; 2020 Nov; 100(42):3323-3327. PubMed ID: 33202495
[No Abstract] [Full Text] [Related]
7. Tumor microenvironment-responsive polymer with chlorin e6 to interface hollow mesoporous silica nanoparticles-loaded oxygen supply factor for boosted photodynamic therapy.
Wang X; Ding X; Yu B; Zhang X; Shen Y; Cong H
Nanotechnology; 2020 Jul; 31(30):305709. PubMed ID: 32299065
[TBL] [Abstract] [Full Text] [Related]
8. ARX788, a novel anti-HER2 antibody-drug conjugate, shows anti-tumor effects in preclinical models of trastuzumab emtansine-resistant HER2-positive breast cancer and gastric cancer.
Barok M; Le Joncour V; Martins A; Isola J; Salmikangas M; Laakkonen P; Joensuu H
Cancer Lett; 2020 Mar; 473():156-163. PubMed ID: 31904483
[TBL] [Abstract] [Full Text] [Related]
9. Optimal Target Delineation and treatment Techniques in the Era of Conformal Photon and Proton breast and Regional Nodal Irradiation.
Kowalski ES; Feigenberg SJ; Cohen J; Fellows Z; Vadnais P; Rice S; Mishra MV; Molitoris JK; Nichols EM; Snider JW
Pract Radiat Oncol; 2020; 10(3):174-182. PubMed ID: 31786234
[TBL] [Abstract] [Full Text] [Related]
10. A Novel Anti-HER2 Antibody-Drug Conjugate XMT-1522 for HER2-Positive breast and Gastric cancers Resistant to Trastuzumab Emtansine.
Le Joncour V; Martins A; Puhka M; Isola J; Salmikangas M; Laakkonen P; Joensuu H; Barok M
Mol Cancer Ther; 2019 Oct; 18(10):1721-1730. PubMed ID: 31292166
[TBL] [Abstract] [Full Text] [Related]
11. Incidence of radionecrosis in single-fraction radiosurgery compared with fractionated radiotherapy in the treatment of brain metastasis.
Donovan EK; Parpia S; Greenspoon JN
Curr Oncol; 2019 Jun; 26(3):e328-e333. PubMed ID: 31285676
[TBL] [Abstract] [Full Text] [Related]
12. Hypofractionated postmastectomy radiotherapy with helical tomotherapy in patients with immediate breast reconstruction: dosimetric results and acute/intermediate toxicity evaluation.
Orecchia R; Rojas DP; Cattani F; Ricotti R; Santoro L; Morra A; Cambria R; Luraschi R; Dicuonzo S; Ronchi S; Surgo A; Dell' Acqua V; Veronesi P; De Lorenzi F; Fodor C; Leonardi MC; Jereczek-Fossa BA
Med Oncol; 2018 Feb; 35(3):39. PubMed ID: 29442173
[TBL] [Abstract] [Full Text] [Related]
13. Exercise following breast cancer: exploratory survival analyses of two randomised, controlled trials.
Hayes SC; Steele ML; Spence RR; Gordon L; Battistutta D; Bashford J; Pyke C; Saunders C; Eakin E
Breast Cancer Res Treat; 2018 Jan; 167(2):505-514. PubMed ID: 29063309
[TBL] [Abstract] [Full Text] [Related]
14. Biopsy of enlarging lesions after stereotactic radiosurgery for brain metastases frequently reveals radiation necrosis.
Narloch JL; Farber SH; Sammons S; McSherry F; Herndon JE; Hoang JK; Yin FF; Sampson JH; Fecci PE; Blackwell KL; Kirkpatrick JP; Kim GJ
Neuro Oncol; 2017 Oct; 19(10):1391-1397. PubMed ID: 28472527
[TBL] [Abstract] [Full Text] [Related]
15. Cross-sectional imaging to evaluate the extent of regional nodal disease in breast cancer patients undergoing neoadjuvant systemic therapy.
Anderson TL; Glazebrook KN; Murphy BL; Viers LD; Hieken TJ
Eur J Radiol; 2017 Apr; 89():163-168. PubMed ID: 28267534
[TBL] [Abstract] [Full Text] [Related]
16. [A Study of Gemctabine plus Nab-Paclitaxel Therapy for Advanced Local Progressive Pancreatic cancer].
Itoh Y; Saito H; Yamagishi S; Suematsu Y; Takahashi M; Nakayama M; Fukabori M; Morita A; Wakabayashi K
Gan To Kagaku Ryoho; 2016 Nov; 43(12):1681-1683. PubMed ID: 28133097
[TBL] [Abstract] [Full Text] [Related]
17. Association Between Radiation Necrosis and Tumor Biology After Stereotactic Radiosurgery for Brain Metastasis.
Miller JA; Bennett EE; Xiao R; Kotecha R; Chao ST; Vogelbaum MA; Barnett GH; Angelov L; Murphy ES; Yu JS; Ahluwalia MS; Suh JH; Mohammadi AM
Int J Radiat Oncol Biol Phys; 2016 Dec; 96(5):1060-1069. PubMed ID: 27742540
[TBL] [Abstract] [Full Text] [Related]
18. Expansive hematoma in delayed cerebral radiation necrosis in patients treated with T-DM1: a report of two cases.
Mitsuya K; Watanabe J; Nakasu Y; Hayashi N; Harada H; Ito I
BMC Cancer; 2016 Jul; 16():391. PubMed ID: 27377061
[TBL] [Abstract] [Full Text] [Related]
19. Radionecrosis after stereotactic radiotherapy for brain metastases.
Le Rhun E; Dhermain F; Vogin G; Reyns N; Metellus P
Expert Rev Neurother; 2016 Aug; 16(8):903-14. PubMed ID: 27177183
[TBL] [Abstract] [Full Text] [Related]
20. Impact of a nurse navigator on genomic testing and timely treatment decision making in patients with breast cancer.
McAllister KA; Schmitt ML
Clin J Oncol Nurs; 2015 Oct; 19(5):510-2. PubMed ID: 26414569
[TBL] [Abstract] [Full Text] [Related]
[Next]
